#ACR25 Best Abstracts - Day 3 Tweeting about an ACR presentation or poster is a skill and sometimes art -- one that is mastered by the RheumNow faculty roving the halls and floors for the best new insights at #ACR25, Here are several of the best abstracts from Day 3, as chosen https://t.co/fOgXSiIWzC

Replay of RheumNow Live 2025 - Rheumatoid Arthritis https://t.co/TMC0A11Eil

• Dr. John Cush

Accelerated Aging in Rheumatic Disease: From Biology to Lifestyle Intervention At #ACR25, the session “27M02: Nutrition for Rheumatic Disease: Where Aging Biology, Sarcopenia, and Diet Intersect” invited the audience to view rheumatic disease through the lens of biological https://t.co/OIgh8JQsFa

A Halloween ACR Guidance (10.31.25) Dr. Jack Cush recaps #ACR25 with suggestions on how to best learn ACR25 content from RheumNow and our Videos and podcasts. https://t.co/ik5n4jA3LK https://t.co/lr65m8kRxx

• https://buff.ly/p2Odily

The Great Debate – Who Really Won? #ACR25 https://t.co/bh0wxXpVXa https://t.co/Wr8eeW1KsQ

• The Great Debate – Who Really Won? | RheumNow

The Decade Ahead: Predicting Long-Term Proteinuria Risk in SLE Lupus nephritis affects almost half of patients with SLE and conveys a mortality rate of up to 30% at 10 years, with at least 10-22% of patients developing end-stage kidney disease. Early detection and diagnosis are https://t.co/ggoA2KsqXg

Belimumab Before or After Immunosuppressant Dr. Yuz Yusof reports on abstract 0803 presented at #ACR25 https://t.co/BVFhDDfTvW https://t.co/F9ZvGXIqVn

• Belimumab Before or After Immunosuppressant | RheumNow

Using AI and LLMs in Qualitative Data Dr. Bella Mehta discusses abstract 0794 (Using AI to Analyze Multilingual Qualitative Data in Lupus Pregnancy Research: A Proof of Concept with Large Language Models) presented at #ACR25 https://t.co/HFBuNxdZOF https://t.co/gKAXURq8xR

• Lupus Pregnancy Research: Using AI | RheumNow